Term Gallery logo

Significados de esophageal adenocarcinoma en inglés

Esophageal carcinoma that derives from epithelial cells of glandular origin.

      Uso de esophageal adenocarcinoma en inglés
      1
      Barrett's esophagus is an important step in the pathway to esophageal adenocarcinoma.
      Pubmed
      2
      Context: The incidence of esophageal adenocarcinoma is rising and has surpassed squamous cell carcinoma.
      Pubmed
      3
      Future studies of trastuzumab in esophageal adenocarcinoma are indicated.
      Pubmed
      4
      Barrett's esophagus (BE) is the principal risk factor for esophageal adenocarcinoma.
      Pubmed
      5
      Barrett's esophagus is the precursor lesion for esophageal adenocarcinoma.
      Pubmed
      6
      For esophageal adenocarcinoma, work is needed to develop efficient and effective techniques in mass screening programs.
      Pubmed
      7
      Objectives: Alcohol increases esophageal squamous carcinoma risk but has been less consistently associated with esophageal adenocarcinoma.
      Pubmed
      8
      Barrett's esophagus (BE) is the strongest risk factor for the development of esophageal adenocarcinoma.
      Pubmed
      9
      This review outlines the process of pathogenesis of Barrett's metaplasia and its progression to esophageal adenocarcinoma.
      Pubmed
      10
      Background: The National Comprehensive Cancer Network guidelines recommend consideration of surgery for clinical T4a esophageal adenocarcinoma.
      Pubmed
      11
      Objective: The incidence of esophageal adenocarcinoma has risen rapidly in the past two decades, for unknown reasons.
      Pubmed
      12
      Approximately 80% of high-grade dysplasia and esophageal adenocarcinoma cases demonstrated strong to moderate Akt activity.
      Pubmed
      13
      Reflux-induced injury promotes esophageal adenocarcinoma, one of the most rapidly increasing, highly lethal cancers in Western countries.
      Pubmed
      14
      Surgery should be considered for medically fit patients with cT4aN0-3M0 esophageal adenocarcinoma.
      Pubmed
      15
      Our clinical study indicates esophageal adenocarcinoma patients on metformin had a better treatment response than those without metformin.
      Pubmed
      16
      Background: Barrett's esophagus (BE) is known to progress to esophageal adenocarcinoma in a setting of chronic inflammation.
      Pubmed
      Esta colocación está formada por:
      Esophageal adenocarcinoma por variante geográfica
      Estados Unidos de América
      Común